These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8074640

  • 1. Effects of cromakalim or pinacidil on pacing- and ischemia-induced ventricular fibrillation in the anesthetized pig.
    D'Alonzo AJ, Hess TA, Darbenzio RB, Sewter JC, Conder ML, McCullough JR.
    Basic Res Cardiol; 1994; 89(2):163-76. PubMed ID: 8074640
    [Abstract] [Full Text] [Related]

  • 2. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
    D'Alonzo AJ, Darbenzio RB, Hess TA, Sewter JC, Sleph PG, Grover GJ.
    Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
    [Abstract] [Full Text] [Related]

  • 3. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
    Escande D, Thuringer D, Le Guern S, Courteix J, Laville M, Cavero I.
    Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
    [Abstract] [Full Text] [Related]

  • 4. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
    Baczkó I, Leprán I, Papp JG.
    Eur J Pharmacol; 1997 Apr 11; 324(1):77-83. PubMed ID: 9137916
    [Abstract] [Full Text] [Related]

  • 5. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N, Stuart JS, Lamp ST, Alexander LD, Weiss JN.
    Circ Res; 1992 Dec 11; 71(6):1324-33. PubMed ID: 1423930
    [Abstract] [Full Text] [Related]

  • 6. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.
    Grover GJ, D'Alonzo AJ, Parham CS, Darbenzio RB.
    J Cardiovasc Pharmacol; 1995 Jul 11; 26(1):145-52. PubMed ID: 7564356
    [Abstract] [Full Text] [Related]

  • 7. Effect of cromakalim and pinacidil on 86Rb efflux from guinea pig urinary bladder smooth muscle.
    Trivedi S, Stetz S, Levin R, Li J, Kau S.
    Pharmacology; 1994 Sep 11; 49(3):159-66. PubMed ID: 7972330
    [Abstract] [Full Text] [Related]

  • 8. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium.
    Lau WM.
    Pharmacology; 1992 Sep 11; 45(1):9-16. PubMed ID: 1508969
    [Abstract] [Full Text] [Related]

  • 9. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T, Teshigawara T, Taira N.
    Br J Pharmacol; 1990 Sep 11; 101(1):157-65. PubMed ID: 2149290
    [Abstract] [Full Text] [Related]

  • 10. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H, Kitagaki K, Goto S, Suda H, Koda A.
    Jpn J Pharmacol; 1991 May 11; 56(1):13-21. PubMed ID: 1831870
    [Abstract] [Full Text] [Related]

  • 11. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A, Hellegouarch A.
    J Am Coll Cardiol; 1994 Feb 11; 23(2):487-96. PubMed ID: 8294705
    [Abstract] [Full Text] [Related]

  • 12. Effects of the potassium channel openers cromakalim and pinacidil on catecholamine secretion and calcium mobilization in cultured bovine adrenal chromaffin cells.
    Masuda Y, Yoshizumi M, Ishimura Y, Katoh I, Oka M.
    Biochem Pharmacol; 1994 May 18; 47(10):1751-8. PubMed ID: 7515621
    [Abstract] [Full Text] [Related]

  • 13. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A, Szerdahelyi P, Engelman RM, Das DK.
    J Pharmacol Exp Ther; 1993 Dec 18; 267(3):1355-62. PubMed ID: 8263798
    [Abstract] [Full Text] [Related]

  • 14. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return.
    Gotanda K, Yokoyama H, Satoh K, Taira N.
    Cardiovasc Drugs Ther; 1989 Aug 18; 3(4):507-15. PubMed ID: 2488102
    [Abstract] [Full Text] [Related]

  • 15. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators.
    Fish FA, Prakash C, Roden DM.
    Circulation; 1990 Oct 18; 82(4):1362-9. PubMed ID: 1698129
    [Abstract] [Full Text] [Related]

  • 16. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K, Matsuda T, Asano M.
    Br J Pharmacol; 1990 May 18; 100(1):143-9. PubMed ID: 2115387
    [Abstract] [Full Text] [Related]

  • 17. Effects of intracoronary cromakalim, pinacidil, or diltiazem on cesium chloride-induced arrhythmias in anesthetized dogs under conditions of controlled coronary blood flow.
    D'Alonzo AJ, Hess TA, Darbenzio RB, Sewter JC.
    J Cardiovasc Pharmacol; 1993 Apr 18; 21(4):677-83. PubMed ID: 7681916
    [Abstract] [Full Text] [Related]

  • 18. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
    Stockbridge N, Zhang H, Weir B.
    Biochem Biophys Res Commun; 1991 Nov 27; 181(1):172-8. PubMed ID: 1958186
    [Abstract] [Full Text] [Related]

  • 19. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P, Szilvássy Z, Droy-Lefaix MT, Tarrade T, Koltai M.
    Cardiovasc Res; 1995 Nov 27; 30(5):781-7. PubMed ID: 8595627
    [Abstract] [Full Text] [Related]

  • 20. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H.
    J Cardiovasc Pharmacol; 1993 Dec 27; 22(6):863-8. PubMed ID: 7509906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.